Application  	Application  	 NN	O
of  	of  	 IN	O
basic  	basic  	 JJ	O
research  	research  	 NN	O
to  	to  	 TO	O
development  	development  	 NN	O
of  	of  	 IN	O
diagnostics  	diagnostics  	 NNS	O
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
against  	against  	 IN	O
inflammatory  	inflammatory  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
Biomarkers  	Biomarkers  	 NNS	I-NP
are  	are  	 VBP	O
generally  	generally  	 RB	O
important  	important  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
points  	points  	 NNS	O
of  	of  	 IN	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
disease 	disease 	 NN	O
,  	,  	 ,	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
cure 	cure 	 NN	O
,  	,  	 ,	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
prognosis  	prognosis  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
metastasis  	metastasis  	 NN	B-NP
or  	or  	 CC	O
recurrence 	recurrence 	 NN	O
,  	,  	 ,	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
disease 	disease 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
prediction  	prediction  	 NN	O
of  	of  	 IN	O
drug  	drug  	 NN	B-NP
efficacy 	efficacy 	 NN	I-NP
.  	.  	 .	O
Currently  	Currently  	 RB	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
well  	well  	 RB	O
accepted  	accepted  	 VBN	O
that  	that  	 IN	O
allergic  	allergic  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
bronchial  	bronchial  	 JJ	B-NP
asthma  	asthma  	 NN	I-NP
and  	and  	 CC	O
atopic  	atopic  	 JJ	B-NP
dermatitis  	dermatitis  	 NNS	I-NP
are  	are  	 VBP	O
not  	not  	 RB	O
single  	single  	 JJ	O
diseases 	diseases 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
syndromes  	syndromes  	 JJ	O
encompassing  	encompassing  	 JJ	O
different  	different  	 JJ	O
diseases  	diseases  	 NNS	O
entities 	entities 	 NNS	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
important  	important  	 JJ	O
to  	to  	 TO	O
cluster  	cluster  	 VB	O
allergic  	allergic  	 JJ	B-NP
disease  	disease  	 NN	I-NP
patients  	patients  	 NNS	I-NP
to  	to  	 TO	O
assess  	assess  	 VB	O
prognosis  	prognosis  	 NNS	O
or  	or  	 CC	O
the  	the  	 DT	O
choice  	choice  	 NN	O
of  	of  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
useful  	useful  	 JJ	O
biomarkers  	biomarkers  	 NNS	B-NP
are  	are  	 VBP	O
required  	required  	 VBN	O
for  	for  	 IN	O
these  	these  	 DT	O
purposes 	purposes 	 NNS	O
.  	.  	 .	O
Periostin 	Periostin 	 NNP	B-NP
,  	,  	 ,	O
an  	an  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
protein 	protein 	 NN	I-NP
,  	,  	 ,	O
has  	has  	 VBZ	O
recently  	recently  	 RB	O
emerged  	emerged  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
biomarker  	biomarker  	 JJ	B-NP
useful  	useful  	 JJ	I-NP
for  	for  	 IN	O
clustering  	clustering  	 JJ	O
asthma  	asthma  	 NN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
further  	further  	 RB	O
found  	found  	 VBN	O
that  	that  	 IN	O
periostin  	periostin  	 NN	B-NP
plays  	plays  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
allergic  	allergic  	 JJ	B-NP
inflammation  	inflammation  	 NN	I-NP
and  	and  	 CC	O
based  	based  	 VBN	O
on  	on  	 IN	O
this  	this  	 DT	O
finding  	finding  	 VBG	O
we  	we  	 PRP	O
are  	are  	 VBP	O
now  	now  	 RB	O
developing  	developing  	 VBG	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
targeting  	targeting  	 VBG	I-NP
periostin  	periostin  	 NN	I-NP
against  	against  	 IN	O
allergic  	allergic  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
periostin  	periostin  	 NN	B-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	O
various  	various  	 JJ	O
inflammatory  	inflammatory  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
in  	in  	 IN	O
addition  	addition  	 NN	O
to  	to  	 TO	O
allergic  	allergic  	 VB	B-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
diagnostics  	diagnostics  	 NNS	O
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
many  	many  	 JJ	O
inflammatory  	inflammatory  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
article 	article 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
describe  	describe  	 VBP	O
the  	the  	 DT	O
history  	history  	 NN	O
of  	of  	 IN	O
periostin  	periostin  	 JJ	B-NP
research  	research  	 NN	I-NP
and  	and  	 CC	O
our  	our  	 PRP$	O
application  	application  	 NN	O
of  	of  	 IN	O
basic  	basic  	 JJ	O
research  	research  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
diagnostics  	diagnostics  	 NNS	O
and  	and  	 CC	O
therapeutic  	therapeutic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
against  	against  	 IN	O
inflammatory  	inflammatory  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
